These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2792019)

  • 1. Sepsis following injection of obstructed pancreatic ducts.
    Ayela P; Ponchon T; Valette PJ; Chavaillon A
    Endoscopy; 1989 Sep; 21(5):242. PubMed ID: 2792019
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of post-ERCP pancreatitis: a little antacid might go a long way.
    Nagar AB; Gorelick F
    Gut; 2008 Nov; 57(11):1492-3. PubMed ID: 18941003
    [No Abstract]   [Full Text] [Related]  

  • 3. The immediate effects of retrograde pancreatography on the pancreas.
    Kivisaari L; Alitalo I
    Eur J Radiol; 1984 Feb; 4(1):58-60. PubMed ID: 6723675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the rate of post-ERCP pancreatitis not reduced by guide-wire cannulation?
    Park DH; Lee SS; Seo DW; Lee SK; Kim MH
    Endoscopy; 2008 Sep; 40(9):784; author reply 785. PubMed ID: 18773344
    [No Abstract]   [Full Text] [Related]  

  • 5. ERCP and endoscopic sphincterotomy-induced pancreatitis.
    Sherman S
    Am J Gastroenterol; 1994 Mar; 89(3):303-5. PubMed ID: 8122635
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic guidewire technique increases the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fukasawa M; Takano S; Enomoto N
    Dig Endosc; 2016 Apr; 28 Suppl 1():102-3. PubMed ID: 26683883
    [No Abstract]   [Full Text] [Related]  

  • 7. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Cotton PB; Brazer SR
    Am J Gastroenterol; 1992 May; 87(5):683; author reply 684-5. PubMed ID: 1595670
    [No Abstract]   [Full Text] [Related]  

  • 8. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Banerjee A
    Am J Gastroenterol; 1992 May; 87(5):683-4; author reply 684-5. PubMed ID: 1595671
    [No Abstract]   [Full Text] [Related]  

  • 9. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Short TP; Thomas E
    Am J Gastroenterol; 1992 May; 87(5):682-3; author reply 684-5. PubMed ID: 1595669
    [No Abstract]   [Full Text] [Related]  

  • 10. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain.
    Silverman WB
    Gastrointest Endosc; 2007 Jun; 65(7):969-70. PubMed ID: 17531629
    [No Abstract]   [Full Text] [Related]  

  • 11. [In patients undergoing precut biliary sphincterotomy during endoscopic retrograde cholangiopancreatography (ERCP) to facilitate biliary access, is endoscopic pancreatic duct stenting indicated to prevent pancreatitis?].
    Igea Arisqueta F
    Gastroenterol Hepatol; 2009 Mar; 32(3):171-2. PubMed ID: 19231033
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
    Sofuni A; Maguchi H; Itoi T; Katanuma A; Hisai H; Niido T; Toyota M; Fujii T; Harada Y; Takada T
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1339-46. PubMed ID: 17981247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Freeman ML
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1354-65. PubMed ID: 17981248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
    Tarnasky P; Cunningham J; Cotton P; Hoffman B; Palesch Y; Freeman J; Curry N; Hawes R
    Endoscopy; 1997 May; 29(4):252-7. PubMed ID: 9255527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intraductal papillary mucinous neoplasm really a risk factor of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic stenting?
    Kuwatani M; Kawakami H; Kato M
    Intern Med; 2012; 51(10):1285; author reply 1287. PubMed ID: 22687810
    [No Abstract]   [Full Text] [Related]  

  • 16. Biliary cannulation during endoscopic retrograde cholangiopancreatography: core technique and recent innovations.
    Bourke MJ; Costamagna G; Freeman ML
    Endoscopy; 2009 Jul; 41(7):612-7. PubMed ID: 19588290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography.
    Aliperti G
    Gastrointest Endosc Clin N Am; 1996 Apr; 6(2):379-407. PubMed ID: 8673333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatitis as a fatal iatrogenic complication of opisthorchiasis].
    Osipenkova TK; Fedulova MV; Bogomolov DV; Baranova MIa
    Sud Med Ekspert; 2010; 53(2):53-5. PubMed ID: 20560515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial.
    Tsuchiya T; Itoi T; Sofuni A; Itokawa F; Kurihara T; Ishii K; Tsuji S; Kawai T; Moriyasu F
    J Hepatobiliary Pancreat Surg; 2007; 14(3):302-7. PubMed ID: 17520207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
    Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
    Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.